No need for needles: Botox sponge treats intrinsic rhinitis

Oct 15, 2009

Injecting botulinum toxin (botox) to treat intrinsic or allergic rhinitis may be a thing of the past as researchers have now shown that sponges soaked in botox are equally effective in treating the condition. The research published in BioMed Central's open access journal Head & Face Medicine offers a potential needle-free treatment to the millions of people who suffer from rhinitis.

Rainer Laskawi (ENT-Department) worked with a team of researchers from the University Medical Center Göttingen, Germany, to test the effectiveness of the botox sponge. He said, "Intrinsic rhinitis affects a lot of patients and can be quite disabling for the patient. Botox injections can help, and we wanted to explore a less invasive alternative".

The researchers inserted sponges into the patients' nostrils for 30 minutes, which were soaked with directly after the insertion. The patients then kept a 'nose diary' for the next twelve weeks, detailing sneezes per day, tissues used and a 'congestion score'. A group of patients who received the treatment scored better on all aspects. According to Laskawi, "We've shown that the minimally invasive application method of BTA with a sponge is a safe, painless method which can lead to a long lasting reduction of nasal hypersecretion".

It may be hypothized that there exits a certain form of a "botulinum toxin-sensitive" intrinsic rhinitis.

More information: Minimally invasive application of A in patients with idiopathic , Saskia Rohrbach, Katharina Junghans, Sibylle Köhler and Rainer Laskawi, Head & Face Medicine (in press), http://www.head-face-med.com/

Source: BioMed Central (news : web)

Explore further: 'Ice Bucket Challenge' passes $100 mn mark

add to favorites email to friend print save as pdf

Related Stories

Botox for newborns

Mar 17, 2008

Botulinum toxin, also called Botox, is best known as one of the most commonly used molecules to reduce wrinkles. It is also known as one of the most poisonous naturally occurring substances.

Dysport the newest wrinkle-stopping drug to hit market

May 13, 2009

There's a new wrinkle remover on the market. Late last month, the U.S. Food and Drug Administration sanctioned Dysport for cosmetic and therapeutic use. Like Botox, it's an injectable drug derived from a botulinum toxin. ...

Recommended for you

Cold cash just keeps washing in from ALS challenge

Aug 28, 2014

In the couple of hours it took an official from the ALS Association to return a reporter's call for comment, the group's ubiquitous "ice bucket challenge" had brought in a few million more dollars.

Medtronic spends $350M on another European deal

Aug 27, 2014

U.S. medical device maker Medtronic is building stronger ties to Europe, a couple months after announcing a $42.9 billion acquisition that involves moving its main executive offices across the Atlantic, where it can get a ...

Mind over matter for people with disabilities

Aug 26, 2014

People with serious physical disabilities are unable to do the everyday things that most of us take for granted despite having the will – and the brainpower – to do so. This is changing thanks to European ...

User comments : 0